OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FusionGDB 2.0: fusion gene annotation updates aided by deep learning
Pora Kim, Hua Tan, Jiajia Liu, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1221-D1230
Open Access | Times Cited: 27
Pora Kim, Hua Tan, Jiajia Liu, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1221-D1230
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Clinically relevant fusion oncogenes: detection and practical implications
Maxim Sorokin, Elizaveta Rabushko, Julian M. Rozenberg, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 24
Maxim Sorokin, Elizaveta Rabushko, Julian M. Rozenberg, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 24
Artificial intelligence in fusion protein three‐dimensional structure prediction: Review and perspective
Himansu Kumar, Pora Kim
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 5
Himansu Kumar, Pora Kim
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 5
Aberrant phase separation drives membranous organelle remodeling and tumorigenesis
Xinyu Wang, Amin Jiang, Quan Meng, et al.
Molecular Cell (2025)
Closed Access
Xinyu Wang, Amin Jiang, Quan Meng, et al.
Molecular Cell (2025)
Closed Access
Translational transcriptomics for personalized oncology
Anton Buzdin, Alexander Seryakov, Marianna Zolotovskaia, et al.
Elsevier eBooks (2025), pp. 331-396
Closed Access
Anton Buzdin, Alexander Seryakov, Marianna Zolotovskaia, et al.
Elsevier eBooks (2025), pp. 331-396
Closed Access
Identification of a novel NRF1::PDGFRA fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
Jialong Liu, Yaqing Feng, Yanfang Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jialong Liu, Yaqing Feng, Yanfang Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
FusionPub, a therapeutic landscape of human fusion genes
Himansu Kumar, Abayomi Adegunlehin, Zikang Chen, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Himansu Kumar, Abayomi Adegunlehin, Zikang Chen, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Single-cell multi-omics elucidates the role of RPS27-RPS24 fusion gene in osteosarcoma chemoresistance and metabolic regulation
Zhiwei Tao, Ping-An Zou, Zhenzhong Yang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Zhiwei Tao, Ping-An Zou, Zhenzhong Yang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours
Rafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, et al.
The Journal of Pathology Clinical Research (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 2
Rafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, et al.
The Journal of Pathology Clinical Research (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 2
Transcriptome-wide association analysis identifies candidate susceptibility genes for prostate-specific antigen levels in men without prostate cancer
Dorothy M. Chen, Ruocheng Dong, Linda Kachuri, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100315-100315
Open Access | Times Cited: 2
Dorothy M. Chen, Ruocheng Dong, Linda Kachuri, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100315-100315
Open Access | Times Cited: 2
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
Monica F. Chen, Soo‐Ryum Yang, Jessica J. Tao, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3812-3823
Closed Access | Times Cited: 2
Monica F. Chen, Soo‐Ryum Yang, Jessica J. Tao, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3812-3823
Closed Access | Times Cited: 2
FusionPDB: a knowledgebase of human fusion proteins
Himansu Kumar, Lin-Ya Tang, Chengyuan Yang, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1289-D1304
Open Access | Times Cited: 6
Himansu Kumar, Lin-Ya Tang, Chengyuan Yang, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1289-D1304
Open Access | Times Cited: 6
FusionNeoAntigen: a resource of fusion gene-specific neoantigens
Himansu Kumar, Ruihan Luo, Jianguo Wen, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1276-D1288
Open Access | Times Cited: 6
Himansu Kumar, Ruihan Luo, Jianguo Wen, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1276-D1288
Open Access | Times Cited: 6
Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia
Chi‐Keung Cheng, Yuk‐Lin Yung, Hoi–Yun Chan, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Chi‐Keung Cheng, Yuk‐Lin Yung, Hoi–Yun Chan, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Diffusion-enhanced characterization of 3D chromatin structure reveals its linkage to gene regulatory networks and the interactome
Yueying He, Yue Xue, Jingyao Wang, et al.
Genome Research (2023) Vol. 33, Iss. 8, pp. 1354-1368
Open Access | Times Cited: 4
Yueying He, Yue Xue, Jingyao Wang, et al.
Genome Research (2023) Vol. 33, Iss. 8, pp. 1354-1368
Open Access | Times Cited: 4
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series
Jamie O. Brett, Lauren L. Ritterhouse, Erik T. Newman, et al.
The Oncologist (2022) Vol. 28, Iss. 2, pp. 172-179
Open Access | Times Cited: 7
Jamie O. Brett, Lauren L. Ritterhouse, Erik T. Newman, et al.
The Oncologist (2022) Vol. 28, Iss. 2, pp. 172-179
Open Access | Times Cited: 7
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer
Carolin Schimmelpfennig, Michael Rade, Susanne Füssel, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Carolin Schimmelpfennig, Michael Rade, Susanne Füssel, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis
Sun-Young Jung, Seung Tae Kim, Jihoon Ko, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 3
Sun-Young Jung, Seung Tae Kim, Jihoon Ko, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 3
FusionNW, a potential clinical impact assessment of kinases in pan-cancer fusion gene network
Chengyuan Yang, Himansu Kumar, Pora Kim
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access
Chengyuan Yang, Himansu Kumar, Pora Kim
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access
CDC42BPA::BRAF Represents a Novel Fusion in Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma
Maria Isabel Barros Guinle, Jeffrey Nirschl, Yao Lulu Xing, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
Maria Isabel Barros Guinle, Jeffrey Nirschl, Yao Lulu Xing, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access
Transformers meets neoantigen detection: a systematic literature review
Vicente Machaca, Valeria Goyzueta, María Graciel Cruz, et al.
Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics (2024) Vol. 21, Iss. 2
Open Access
Vicente Machaca, Valeria Goyzueta, María Graciel Cruz, et al.
Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics (2024) Vol. 21, Iss. 2
Open Access
Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts
Oğuzhan Karaosmanoğlu
Advances in Medical Sciences (2024)
Closed Access
Oğuzhan Karaosmanoğlu
Advances in Medical Sciences (2024)
Closed Access
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening Cohort
Stefan T. Kaluziak, Elizabeth Codd, Rashi Purohit, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Stefan T. Kaluziak, Elizabeth Codd, Rashi Purohit, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Systematic investigation of the homology sequences around the human fusion gene breakpoints in pan-cancer – bioinformatics study for a potential link to MMEJ
Pora Kim, Himansu Kumar, Chengyuan Yang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 5
Open Access | Times Cited: 1
Pora Kim, Himansu Kumar, Chengyuan Yang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 5
Open Access | Times Cited: 1
Long G4-rich enhancer physically interacts with EXOC3 promoter via a G4:G4 DNA-based mechanism
Jeffrey D. DeMeis, Justin T. Roberts, Haley A Delcher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jeffrey D. DeMeis, Justin T. Roberts, Haley A Delcher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Long G4-rich enhancers target promoters via a G4 DNA-based mechanism
Jeffrey D. DeMeis, Justin T. Roberts, Haley A Delcher, et al.
Nucleic Acids Research (2024)
Open Access
Jeffrey D. DeMeis, Justin T. Roberts, Haley A Delcher, et al.
Nucleic Acids Research (2024)
Open Access
